We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $2.41B
1-Year Est. Return 44.07%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+44.07%
3 Year Est. Return
+212.37%
5 Year Est. Return
+206.87%
10 Year Est. Return
+857.96%
AUM
$1.16B
AUM Growth
+$57.7M
Cap. Flow
-$5.39M
Cap. Flow %
-0.47%
Top 10 Hldgs %
87.32%
Holding
56
New
–
Increased
2
Reduced
6
Closed
–

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$10M
2
ZBH icon
Zimmer Biomet
ZBH
+$60.6K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.52M
2
BAX icon
Baxter International
BAX
+$3.75M
3
WSM icon
Williams-Sonoma
WSM
+$2.17M
4
DIS icon
Walt Disney
DIS
+$891K
5
AMZN icon
Amazon
AMZN
+$103K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 62.11%
2 Healthcare 24.58%
3 Technology 5.11%
4 Communication Services 3.16%
5 Consumer Staples 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$27.1B
$712M 61.62%
8,028,740
-25,600
-0.3% -$2.17M
ZTS icon
2
Zoetis
ZTS
$29B
$45.2M 3.91%
232,639
-100
-0% -$20.2K
AAPL icon
3
Apple
AAPL
$4.81T
$38.7M 3.35%
273,800
– –
ABT icon
4
Abbott
ABT
$175B
$38.1M 3.3%
322,830
– –
LLY icon
5
Eli Lilly
LLY
$1.06T
$34.2M 2.96%
148,023
– –
ELAN icon
6
Elanco Animal Health
ELAN
$11.3B
$31.8M 2.75%
997,171
+298,000
+43% +$10M
DIS icon
7
Walt Disney
DIS
$182B
$31.2M 2.7%
184,300
-5,000
-3% -$891K
ABBV icon
8
AbbVie
ABBV
$465B
$27.2M 2.35%
251,760
– –
BMY icon
9
Bristol-Myers Squibb
BMY
$128B
$25.3M 2.19%
426,964
– –
JNJ icon
10
Johnson & Johnson
JNJ
$645B
$25.2M 2.18%
156,030
– –
MSFT icon
11
Microsoft
MSFT
$3.78T
$20M 1.73%
70,850
– –
ZBH icon
12
Zimmer Biomet
ZBH
$17.4B
$14.3M 1.24%
100,734
+412
+0.4% +$60.6K
PFE icon
13
Pfizer
PFE
$164B
$14.1M 1.22%
327,101
– –
MRK icon
14
Merck
MRK
$368B
$12.7M 1.1%
169,250
-112,000
-40% -$8.52M
CAT icon
15
Caterpillar
CAT
$380B
$11.5M 1%
60,000
– –
KMB icon
16
Kimberly-Clark
KMB
$32.9B
$11.3M 0.97%
85,000
– –
MA icon
17
Mastercard
MA
$494B
$6.95M 0.6%
20,000
– –
PG icon
18
Procter & Gamble
PG
$344B
$6.27M 0.54%
44,871
– –
BAX icon
19
Baxter International
BAX
$12.1B
$5.37M 0.46%
66,700
-47,500
-42% -$3.75M
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.08T
$4.94M 0.43%
18,108
– –
CI icon
21
Cigna
CI
$72.7B
$4.92M 0.43%
24,587
– –
AMZN icon
22
Amazon
AMZN
$2.66T
$4.2M 0.36%
25,560
-600
-2% -$103K
EPD icon
23
Enterprise Products Partners
EPD
$77.8B
$3.24M 0.28%
149,570
– –
MDT icon
24
Medtronic
MDT
$111B
$3.03M 0.26%
24,177
– –
MMP
25
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.5M 0.22%
54,800
– –

Similar funds

Blackhill Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Blackhill Capital held 56 positions worth $1.16B, up 5.3% from $1.1B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Blackhill Capital opened no new positions and made no exits, leaving the 56-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 62% of assets, up from 59% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital added most to Elanco Animal Health in Q3 2021, an estimated $10M increase.
  • Blackhill Capital's biggest Q3 2021 reduction was Merck, cutting an estimated $8.52M.
  • Blackhill Capital's ten largest holdings make up 87% of its $1.16B portfolio in Q3 2021.
  • Blackhill Capital opened 0 new positions and closed 0 in Q3 2021.
  • Blackhill Capital's portfolio value rose 5.3% quarter-over-quarter to $1.16B.

Based on Blackhill Capital's 13F filing for Q3 2021, filed 12 Nov 2021.